TM
MRVL icon

Thrax Management’s Marvell Technology MRVL Stock Holding History

Thrax Management’s Portfolio MRVL Stock Details MRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$554K Buy
+40,000
New +$545K 0.1% 157

Other funds holding MRVL

SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IIM
Ivory Investment Management New York $496M AUM 4.8% 1-Year Est. Return

Thrax Management's MRVL Position: Q4 2016 in Review

Thrax Management increased its Marvell Technology (MRVL) stake by 94% in Q4 2016, buying an estimated $2.75M and bringing the position to 417,254 shares worth $5.79M. The position accounts for 1.06% of the portfolio, ranked #25.

Thrax Management first reported a position in MRVL in Q3 2016 and has held it in 2 quarters since. 340 funds tracked by Wall St. Rank hold MRVL as of Q4 2016.

  • Thrax Management held 417,254 shares of Marvell Technology worth $5.79M as of Q4 2016.
  • Thrax Management bought 202,254 Marvell Technology shares in Q4 2016, an estimated $2.75M.
  • Marvell Technology made up 1.06% of Thrax Management's portfolio in Q4 2016, its #25 holding.
  • Thrax Management first reported a position in Marvell Technology in Q3 2016 and has held it in 2 quarters since.
  • 340 funds tracked by Wall St. Rank held Marvell Technology as of Q4 2016.

Based on Thrax Management's 13F filing for Q4 2016, filed 16 Feb 2017.